Irish Child Health Database - Peer Reviewed Papers
Your search returns 1 documents
1. High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
Background: The current standard treatment for patients with high-risk neuroblastoma includes initial induction chemotherapy with a 21-day interval between induction treatments. We aimed to assess whether an intensive chemotherapy protocol that had a 10-day interval between treatments would improve event-free survival (EFS) in patients aged 1 year or over with high-risk neuroblastoma. more...
Evaluation of the effectiveness of treatments - neuroblastoma
chemotherapy for neuroblastoma
The Lancet Oncology, Vol: 9 Page: 247-256 2008
A. D. Pearson; C. R. Pinkerton; I. J. Lewis; J. Imeson; C. Ellershaw; D. Machin